HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Porter, W. C. Articles by Dworkin, H. J. Search for Related Content PubMed PubMed Citation Articles by Porter, W. C. Articles by Dworkin, H. J.

Acid-Citrate-Dextrose Compared with Heparin in the Preparation of In Vivo/In Vitro Technetium-99m Red Blood Cells

William Beaumont Hospital, Royal Oak, Michigan

Correspondence: For reprints contact: William C. Porter, Pharm. D. Nuclear Medicine Dept., William Beaumont Hospital, 3601 West 13 Mile Rd., Royal Oak, MI 48072.

ABSTRACT

Red blood cells labeled in vivo/In vitro with Tc-99m (Tc-99m RBC) were prepared in a series of 21 patients and two normal volunteers. In each subject both heparin and acid-citrate-dextrose (ACD) solutions were used to label tandem blood samples. The immediate preinjection binding efficiency (BE) was then determined. In each of the 23 studies, the ACD preparation yielded superior BE. The average BE was 93.47% (±3.78) with ACD and 87.23% (±4.29) with heparin. With the ACD method the effect of carrier Tc-99 may be as great as a 24% reduction in BE observed when initial eluates from long-ingrowth-time generators were used. Improved image quality with minimal renal and urinary-bladder activity results with ACD labeling. It is concluded that the use of ACD results in superior RBC labeling with less nontarget activity relative to heparin and is preferred over heparin for preparing in vivo/In vitro Tc-99m RBC.